Further evaluation revealed that crocetin targets p53-mediated activation of BAX and death domain protein (PIDD)/caspase-2-mediated activation of BID that together converge to mitochondria and cause the loss of transmembrane permeability and activation of caspase cascade in p53-expressing HCT-116 cancer cells. The gene discussed is TP53; the disease is cancer.